DrugDashboards

Market view

olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide · Tablet, Film Coated

20 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Thiazide Diuretic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in shortage right now?
No. FDA does not currently list Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide?
1 company has marketed Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.